When Pfizer, Moderna and Johnson & Johnson announced their Phase 3 clinical trial results, suggesting that their injections were 95 percent, 95 percent and 67 percent effective at preventing infection, respectively, experts cheered.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045